Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Infant Stiff-Joint Syndromes Matched to Possible Genetic Origins

By LabMedica International staff writers
Posted on 25 May 2015
There are over 400 specific disorders that are, or can be, associated with multiple contractures in the newborn and a better understanding of disorders with contractures and their associated genetics is critical for accurate diagnosis and optimal treatment.

Contractures are defined as joints that have reduced range of motion due to stiffening of normally flexible tissues and proper central and peripheral nervous system development and function are required for stimulation of muscle movement. More...
Muscle tissue, ligaments, tendons, and skin require movement for normal development and function, without which, joints develop contractures.

Scientists at the Translational Genomics Research Institute (Phoenix, AZ, USA) and their Canadian colleagues describe over 50 of the more than 400 rare, but specific, disorders associated with multiple muscle contractures and stiff joints among newborns. They affect arms, legs, torsos and other parts of the body, often in combinations. These more than 50 disorders are called "X-linked" syndromes, because the genes that cause them are on the X chromosome and unaffected mothers can pass them on to their children, most often to their sons.

The study, or compilation of studies, identified 20 different genes associated with three categories of these more than 50 syndromes. One category represented more than 20 syndromes in which the responsible X-linked genes have been identified. A second category represented seven distinct reports consistent with X-linkage and present with contractures. A third category represented an additional 20 syndromes with reported contractures that are suspected to be X-linked. The study's goal was to better enable physicians and geneticists to advance new treatments that might help these children.

Judith G. Hall, MD, emerita professor of medical genetics, University of British Columbia (Vancouver, BC, Canada) and a coauthor of the study said, “Clearly, there are many different causes of stiff joints in newborns. We wanted to bring together the clinical description of each of these syndromes, and match them to genes, the biochemistry of genes, and the cellular pathways, in order to identify potential therapies.” The study was published in the May 2015 issue of American Journal of Medical Genetics.

Related Links:

Translational Genomics Research Institute
University of British Columbia 



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.